Multivariate Design of 3D Printed Immediate-Release Tablets with Liquid Crystal-Forming Drug—Itraconazole
Open Access
- 3 November 2020
- Vol. 13 (21), 4961
- https://doi.org/10.3390/ma13214961
Abstract
The simplicity of object shape and composition modification make additive manufacturing a great option for customized dosage form production. To achieve this goal, the correlation between structural and functional attributes of the printed objects needs to be analyzed. So far, it has not been deeply investigated in 3D printing-related papers. The aim of our study was to modify the functionalities of printed tablets containing liquid crystal-forming drug itraconazole by introducing polyvinylpyrrolidone-based polymers into the filament-forming matrices composed predominantly of poly(vinyl alcohol). The effect of the molecular reorganization of the drug and improved tablets’ disintegration was analyzed in terms of itraconazole dissolution. Micro-computed tomography was applied to analyze how the design of a printed object (in this case, a degree of an infill) affects its reproducibility during printing. It was also used to analyze the structure of the printed dosage forms. The results indicated that the improved disintegration obtained due to the use of Kollidon®CL-M was more beneficial for the dissolution of itraconazole than the molecular rearrangement and liquid crystal phase transitions. The lower infill density favored faster dissolution of the drug from printed tablets. However, it negatively affected the reproducibility of the 3D printed object.Keywords
This publication has 76 references indexed in Scilit:
- 3D printing for oral drug delivery: a new tool to customize drug deliveryDrug Delivery and Translational Research, 2020
- 3D printed opioid medicines with alcohol-resistant and abuse-deterrent propertiesInternational Journal of Pharmaceutics, 2020
- Speed it up, slow it down...An issue of bicalutamide release from 3D printed tabletsEuropean Journal of Pharmaceutical Sciences, 2020
- Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing OndansetronPharmaceutics, 2020
- ‘Temporary Plasticiser’: A novel solution to fabricate 3D printed patient-centred cardiovascular ‘Polypill’ architecturesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2018
- Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed TabletsAAPS PharmSciTech, 2018
- 3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and ChallengesPharmaceutical Research, 2018
- 3D-Printed Network Structures as Controlled-Release Drug Delivery Systems: Dose Adjustment, API Release Analysis and PredictionAAPS PharmSciTech, 2018
- Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer fillerInternational Journal of Pharmaceutics, 2018
- Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and PrintabilityJournal of Pharmaceutical Sciences, 2018